Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Breast 4Genitourinary 2

Conditions

Prostatic Neoplasms 1Patient Satisfaction 1Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Docetaxel 409pembrolizumab 332Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Drainage × Genitourinary × Clear all
NCT07474519 2026-03-16

Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer

Ohio State University Comprehensive Cancer Center

Phase 4 Recruiting
40 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT03674996 2023-02-08

Safety and Security Evaluation of Patients Submitted to Minimally Invasive Radical Prostatectomy

Barretos Cancer Hospital

Phase NA Completed
72 enrolled
Genitourinary

Prostatic Neoplasms, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡